Quantitative Systematic Strategies LLC Replimune Group, Inc. Transaction History

Quantitative Systematic Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$28.98 - $39.54 $159,882 - $218,142	-5,517 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$28.5 - $39.37 $81,310 - $112,322	-2,853 Reduced 34.09%	5,517 $212,000
Q1 2021 May 06, 2021	BUY	$30.22 - $45.57 $70,714 - $106,633	2,340 Added 38.81%	8,370 $255,000
Q4 2020 Feb 09, 2021	BUY	$23.5 - $52.65 $141,705 - $317,479	6,030 New	6,030 $230,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.